ArticlePediatric surgery international2025
Outcomes of CDH patients receiving PDA ligation: a propensity score matched analysis.
Article in Pediatric surgery international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeNeonates with congenital diaphragmatic hernia (CDH) have varying severity of pulmonary hypertension (PH) caused by developmental and structural abnormalities of the pulmonary vasculature and exacerbated by hypoxia induced vasoconstriction. Failure of the ductus arteriosus to close postnatally can intermittently shunt blood either to or away from the lungs. We hypothesize patent ductus arteriosus (PDA) ligation can be performed.
methodsWe queried the Congenital Diaphragmatic Hernia Study Group registry to identify patients from 2007 to 2020 who underwent PDA ligation. We excluded patients with missing prenatal data, postnatal diagnosis > 28 days, CDH never repaired, death < 30 days, and PDA ligated on day of or before CDH repair. Patients were matched 4:1 on propensity scores for PDA ligation. The primary outcome was mortality. The secondary outcome was any use of extracorporeal life support (ECLS).
results3953 cases were identified for analysis (3899 in no PDA ligation (-PDAL) group, 54 in PDA ligation (+ PDAL) group). After 4:1 matching, there were 196 in the -PDAL group and 49 in the + PDAL group. There was no significant difference in mortality (OR 1.1, (0.5-2.4), p = 0.811) or in use of ECLS (OR 1.5 (0.8-2.8), p = 0.218) between the two groups.
conclusionsPDA ligation can be considered as a therapeutic option for CDH patients with persistent ductus arteriosus. It may have a role in highly selected cases that have exhausted other therapeutic options. LEVEL OF EVIDENCE: Level III evidence.
Indexed as
Identifiers
40670705What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.